143 related articles for article (PubMed ID: 18272587)
1. CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo.
Petravic J; Loh L; Kent SJ; Davenport MP
J Virol; 2008 Apr; 82(8):4091-101. PubMed ID: 18272587
[TBL] [Abstract][Full Text] [Related]
2. Vaccination and timing influence SIV immune escape viral dynamics in vivo.
Loh L; Petravic J; Batten CJ; Davenport MP; Kent SJ
PLoS Pathog; 2008 Jan; 4(1):e12. PubMed ID: 18225952
[TBL] [Abstract][Full Text] [Related]
3. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques.
Loh L; Batten CJ; Petravic J; Davenport MP; Kent SJ
J Virol; 2007 May; 81(10):5418-22. PubMed ID: 17344299
[TBL] [Abstract][Full Text] [Related]
4. Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection.
Loh L; Reece JC; Fernandez CS; Alcantara S; Center R; Howard J; Purcell DF; Balamurali M; Petravic J; Davenport MP; Kent SJ
PLoS Pathog; 2009 Apr; 5(4):e1000378. PubMed ID: 19360124
[TBL] [Abstract][Full Text] [Related]
5. Quantification of simian immunodeficiency virus cytotoxic T lymphocyte escape mutant viruses.
Loh L; Kent SJ
AIDS Res Hum Retroviruses; 2008 Aug; 24(8):1067-72. PubMed ID: 18620496
[TBL] [Abstract][Full Text] [Related]
6. Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.
Fernandez CS; Stratov I; De Rose R; Walsh K; Dale CJ; Smith MZ; Agy MB; Hu SL; Krebs K; Watkins DI; O'connor DH; Davenport MP; Kent SJ
J Virol; 2005 May; 79(9):5721-31. PubMed ID: 15827187
[TBL] [Abstract][Full Text] [Related]
7. Does cytolysis by CD8+ T cells drive immune escape in HIV infection?
Balamurali M; Petravic J; Loh L; Alcantara S; Kent SJ; Davenport MP
J Immunol; 2010 Nov; 185(9):5093-101. PubMed ID: 20881189
[TBL] [Abstract][Full Text] [Related]
8. Reversion of CTL escape-variant immunodeficiency viruses in vivo.
Friedrich TC; Dodds EJ; Yant LJ; Vojnov L; Rudersdorf R; Cullen C; Evans DT; Desrosiers RC; Mothé BR; Sidney J; Sette A; Kunstman K; Wolinsky S; Piatak M; Lifson J; Hughes AL; Wilson N; O'Connor DH; Watkins DI
Nat Med; 2004 Mar; 10(3):275-81. PubMed ID: 14966520
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.
Fernandez CS; Smith MZ; Batten CJ; De Rose R; Reece JC; Rollman E; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Apr; 81(8):4137-44. PubMed ID: 17251297
[TBL] [Abstract][Full Text] [Related]
10. A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.
Kuwata T; Byrum R; Whitted S; Goeken R; Buckler-White A; Plishka R; Iyengar R; Hirsch VM
J Virol; 2007 Sep; 81(17):8891-904. PubMed ID: 17596304
[TBL] [Abstract][Full Text] [Related]
11. Biphasic CD8+ T-Cell Defense in Simian Immunodeficiency Virus Control by Acute-Phase Passive Neutralizing Antibody Immunization.
Iseda S; Takahashi N; Poplimont H; Nomura T; Seki S; Nakane T; Nakamura M; Shi S; Ishii H; Furukawa S; Harada S; Naruse TK; Kimura A; Matano T; Yamamoto H
J Virol; 2016 Jul; 90(14):6276-6290. PubMed ID: 27122584
[TBL] [Abstract][Full Text] [Related]
12. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
Kent SJ; Fernandez CS; Dale CJ; Davenport MP
Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
[TBL] [Abstract][Full Text] [Related]
13. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
14. Conditional Immune Escape during Chronic Simian Immunodeficiency Virus Infection.
Gellerup DD; Balgeman AJ; Nelson CW; Ericsen AJ; Scarlotta M; Hughes AL; O'Connor SL
J Virol; 2016 Jan; 90(1):545-52. PubMed ID: 26491171
[TBL] [Abstract][Full Text] [Related]
15. Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.
Mandl JN; Regoes RR; Garber DA; Feinberg MB
J Virol; 2007 Nov; 81(21):11982-91. PubMed ID: 17699572
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of immune escape during HIV/SIV infection.
Althaus CL; De Boer RJ
PLoS Comput Biol; 2008 Jul; 4(7):e1000103. PubMed ID: 18636096
[TBL] [Abstract][Full Text] [Related]
17. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of subtype AE simian-human immunodeficiency virus priming and boosting vaccines in pigtail macaques.
De Rose R; Batten CJ; Smith MZ; Fernandez CS; Peut V; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Venturi V; Davenport MP; Kent SJ
J Virol; 2007 Jan; 81(1):292-300. PubMed ID: 17050602
[TBL] [Abstract][Full Text] [Related]
19. Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation.
Kobayashi M; Igarashi H; Takeda A; Kato M; Matano T
J Virol; 2005 Sep; 79(17):11529-32. PubMed ID: 16103206
[TBL] [Abstract][Full Text] [Related]
20. Occult systemic infection and persistent simian immunodeficiency virus (SIV)-specific CD4(+)-T-cell proliferative responses in rhesus macaques that were transiently viremic after intravaginal inoculation of SIV.
McChesney MB; Collins JR; Lu D; Lu X; Torten J; Ashley RL; Cloyd MW; Miller CJ
J Virol; 1998 Dec; 72(12):10029-35. PubMed ID: 9811741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
